SCA
AZN icon

Sandy Cove Advisors’s AstraZeneca AZN Stock Holding History

Sandy Cove Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,000
Closed -$133K – 97
2022
Q1 		$133K Hold
1,000
– – 0.11% 108
2021
Q4 		$117K Buy
+1,000
New +$118K 0.1% 106

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sandy Cove Advisors's AZN Position: Q2 2022 in Review

Sandy Cove Advisors sold out of AstraZeneca (AZN) in Q2 2022, closing a stake of 1,000 shares — an estimated $133K sold.

Sandy Cove Advisors first reported a position in AZN in Q4 2021 and held it in 2 quarters. The position peaked at $133K in Q1 2022. 1,015 funds tracked by Wall St. Rank hold AZN as of Q2 2022.

  • Sandy Cove Advisors reported no remaining AstraZeneca position as of Q2 2022 after selling out during the quarter.
  • Sandy Cove Advisors sold 1,000 AstraZeneca shares in Q2 2022, an estimated $133K.
  • Sandy Cove Advisors first reported a position in AstraZeneca in Q4 2021 and held it in 2 quarters.
  • Sandy Cove Advisors's AstraZeneca position peaked at $133K in Q1 2022.
  • 1,015 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2022.

Based on Sandy Cove Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.